2-aryl-3,4-diazabicyclo(4.n.O)alk-2-en-5-ones for the preparation of an agent for treating cardiac insufficiency

US4772598A · kind A · utility

Assignee

• BASF SE

Inventors

• Karl-Heinz Geiss · Beindersheim, DE
• Phillip A. Rossy · Ludwigshafen, DE
• Marco Thyes
• Horst Koenig
• Hans D. Lehmann · Leutershausen, DE
• Martin Traut · Heidelberg, DE
• Josef Gries · Monsheim, DE

Key dates

• Filing date: Oct 1, 1986
• Grant date: Sep 20, 1988
• Expiry date: Oct 1, 2006

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P9/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

2-aryl-3,4-diazabicyclo[4.n.0]-alk-2-en-5-ones of the formula ##STR1## where m, n, R, R.sup.1, R.sup.2 and R.sup.3 have the stated meanings, are used for the treatment of cardiac insufficiency.